Skip to content
healthcare.dev

Deferasirox

NDC 70700-269, Deferasirox, tablet, from Xiromed, LLC.

Product NDC
70700-269
Status
Listed
Labeler
Xiromed, LLC
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA212995
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70700-269 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DEFERASIROX90 mg/1

Pharmacologic classes

Cytochrome P450 1A2 Inhibitors [MoA]; Cytochrome P450 2C8 Inhibitors [MoA]; Cytochrome P450 3A4 Inducers [MoA]; Iron Chelating Activity [MoA]; Iron Chelator [EPC]

Package NDCNDC-11Package
70700-269-307070002693030 TABLET in 1 BOTTLE, PLASTIC (70700-269-30)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/4c36bb5a-2552-46c1-8500-4ae783cffef1

Use it

Look up 70700-269 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70700-269 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70700-269. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.